Precision Health Clinical Trials

The FOrMe Registry (The German Focal Segmental Glomerulosclerosis and Minimal Change Disease Registry)

Conditions:   Glomerulosclerosis, Focal Segmental;   Minimal Change Disease;   Idiopathic Nephrotic Syndrome
Intervention:   Other: Biosampling
Sponsors:   Volker Burst;   German Research Foundation;   Medical Faculty and the Faculty of Natural Sciences of the University of Cologne;   Cluster of Excellence on Cellular Stress Responses in Ageing-Associated Diseases;   Cologne Center for Genomics
Recruiting

For more information, visit the Study URL.

Prenatal Genetic Diagnosis by Genomic Sequencing

Condition:   Fetal Structural Anomalies
Intervention:   Diagnostic Test: Prenatal Genomic Sequencing
Sponsors:   Columbia University;   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD);   Baylor College of Medicine;   University of North Carolina;   The George Washington University Biostatistics Center;   Oregon Health and Science University
Recruiting

For more information, visit the Study URL.

Evaluating Mutations in MET and TP53 Among Patients Diagnosed With Squamous Cell Carcinoma

Conditions:   Squamous Cell Carcinoma of the Lung;   Squamous Cell Carcinoma of the Head and Neck
Intervention:  
Sponsor:   National University Hospital, Singapore
Recruiting

For more information, visit the Study URL.

Hamburg City Health Study - a German Cohort Study

Conditions:   Coronary Heart Disease;   Stroke;   Dementia;   Cancer;   Health Care;   Vascular Diseases;   Periodontal Diseases;   Ocular Diseases;   Respiratory Disease;   Obesity
Intervention:  
Sponsors:   Universitätsklinikum Hamburg-Eppendorf;   Universitäres Herzzentrum Hamburg-Eppendorf;   Martini-Klinik am UKE GmbH
Recruiting

For more information, visit the Study URL.

Multicenter Prospective Cohort of Kidney Biopsy for Glomerular Disease Research

Conditions:   Glomerular Disease;   Minimal Change Disease;   IgA Nephropathy;   Membranous Nephropathy;   Focal Segmental Glomerulosclerosis;   Lupus Nephritis;   Crescentic Glomerulonephritis
Intervention:   Other: Kidney Biopsy
Sponsors:   Seoul National University Hospital;   Chung-Ang University Hosptial, Chung-Ang University College of Medicine;   KangWon National University Hospital;   Keimyung University Dongsan Medical Center;   SMG-SNU Boramae Medical Center;   Seoul National University Bundang Hospital;   Severance Hospital;   Ministry of Health & Welfare, Korea
Recruiting

For more information, visit the Study URL.

FUlvestrant in Gynecological Cancers That Are Potentially Hormone Sensitive: the FUCHSia Study

Conditions:   Endometrial Stromal Sarcoma;   Adenosarcoma of Uterus;   Leiomyosarcoma Uterus;   Endometrial Cancer;   Sex Cord Stromal Tumor;   Serous Ovarian Tumor
Intervention:   Drug: Fulvestrant
Sponsors:   Frederic Amant;   Kom op tegen Kanker (Stand-up-to-Cancer), the Flemish cancer society;   FWO Research Fund Flanders
Recruiting

For more information, visit the Study URL.

Toripalimab With or Without Celecoxib as Neoadjuvant Therapy in Resectable dMMR/MSI-H Colon Cancer

Conditions:   Colon Cancer;   MSI-H
Interventions:   Drug: Neoadjuvant therapy with PD-1 inhibitor plus COX inhibitor;   Drug: Neoadjuvant therapy with PD-1 inhibitor
Sponsor:   Sun Yat-sen University
Recruiting

For more information, visit the Study URL.

Exploration and Verification of DNA Methylolation in Early Screening of Esophageal Cancer

Condition:   Esophageal Squamous Cell Carcinoma
Intervention:  
Sponsor:   Nanfang Hospital of Southern Medical University
Recruiting

For more information, visit the Study URL.

Immunome Project Consortium for Autoinflammatory Disorders

Condition:   Autoinflammatory Diseases, Hereditary
Intervention:   Diagnostic Test: Collection of biological samples
Sponsor:   Institut National de la Santé Et de la Recherche Médicale, France
Not yet recruiting

For more information, visit the Study URL.

The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)

Conditions:   Cancer, All Types;   Cancer of Liver;   Cancer of Stomach;   Cancer of Head and Neck;   Cancer of Rectum;   Cancer of Kidney;   Cancer of Esophagus;   Cancer of Colon;   Cancer Skin;   Cancer of Cervix;   Cancer, Metastatic;   Cancer of Larynx;   Cancer of Neck;   Cancer of Lung;   Cancer of Brain and Nervous System;   Cancer of Vulva, Disseminated;   Cancer of Pancreas;   Sarcoma;   GIST;   Small-cell Lung Cancer;   Adenocarcinoma Lung;   Cancer of Prostate;   Cancer, Advanced;   Adrenal Cancer;   Testicular Cancer;   Uterine Cancer;   Bronchoalveolar Cell Lung Cancer;   Cancer Unknown Primary;   Glioblastoma Multiforme;   Oligodendroglioma;   Breast Cancer;   Renal Cell Carcinoma;   Hepatocellular Carcinoma;   Cholangiocarcinoma;   Squamous Cell Carcinoma;   Transitional Cell Carcinoma;   Cancer, Other;   Cancer, Anal;   Melanoma;   Cancer, Bile Duct;   Cancer, Bladder;   Cancer Cords Vocal;   Cancers Cell Neuroendocrine;   Cancer Differentiated Poorly;   Cancer, Anaplastic Thyroid
Intervention:  
Sponsors:   SpeciCare;   Dana-Farber Cancer Institute;   Kalispell Regional Medical Center;   Georgia Institute of Technology;   Ontario Institute for Cancer Research;   SEngine Precision Medicine;   Helomics
Recruiting

For more information, visit the Study URL.

Pages